You are about to leave the current site. Are you sure you want to continue?
news
60% reduction of carbon emissions at our production sites in Germany
Environmental impact and sustainability have always played an important role in the KD Pharma Group's approach to business. Minimizing waste and improving overall efficiency are cornerstones of the organization.
We are pleased to announce the opening of our new R&D laboratory and offices at our world-class synthesis and fractionation facility in Seal Sands, UK.
KD Pharma VP of sales, Uwe Westeppe, was interviewed at DCAT week
KD Pharma is a very dynamic, fast-growing company, that is constantly enlarging its technology toolbox for chemical transformations, purification and separation, and encapsulation under cGMP.
KD PHARMA FURTHER EXPANDS ITS CDMO CAPABILITIES IN THE UK MANUFATURING SITE
BIOGGIO, SWITZERLAND – October 18, 2021 – The KD Pharma Group has completed an expansion of its manufacturing site in Seal Sands, United Kingdom. The new modern plant followed a fast-track build project and triples the capacity of the site.